Results 111 to 120 of about 11,268,090 (297)
Molecular Oncology, EarlyView.We established the avian chorioallantoic membrane (CAM) assay as a scalable in vivo model for studying circulating tumor cells (CTCs). Human gastrointestinal tumors spontaneously released genetically validated CTCs that were detected across multiple platforms, demonstrating that the CAM model provides an accessible tool for investigating early cancer ...
Dennis Roth +17 more
wiley +1 more source
Assessment of the coding of ESKD in deaths and hospitalisation data: a working paper [PDF]
, 2014 This working paper uses linked data from Western Australia and New South Wales to assess the likelihood that a patient who is hospitalised with end-stage kidney disease (ESKD) will have ESKD recorded on their death record, in order to establish whether ...
core
Anticoagulation for Atrial Fibrillation in End-stage Kidney Disease
Journal of Controversies in Biomedical Research, 2015 Atrial fibrillation (AF) is the most common arrhythmia in the general population and it has been found to have a higher prevalence in end-stage kidney disease (ESKD).
Gavin Lee, David W Johnson
doaj +1 more source
BMC Nephrology, 2017 BackgroundDietary modification is an important component of the management of end stage kidney disease (ESKD). The diet for ESKD involves modifying energy and protein intake, and altering sodium, phosphate, potassium and fluid intake.
K. Lambert, J. Mullan, K. Mansfield
semanticscholar +1 more source
FEBS Open Bio, EarlyView.The cytoskeleton‐mediated transport of mitochondria via tunnelling nanotubes restores respiration, increases ATP production, rescues cells from apoptosis, activates the AKT/mTOR signalling pathway, promotes cell migration and invasiveness, contributes to cancer progression and treatment resistance.
Stanislava Martínková, Jan Trnka
wiley +1 more source
Kidney and DialysisBackground: Cardiovascular disease is the leading cause of death in chronic kidney disease populations. The risk of major adverse cardiovascular events (MACE) is greater than that of progression to end-stage kidney disease.
Elin Mitford Davies +5 more
doaj +1 more source
Pica in end-stage chronic kidney disease: Literature review
Nefrología (English Edition), 2019 Pica is an individual entity in the patient with chronic kidney disease (CKD), which phenomenon has not been widely studied despite the high reported prevalence.
Claudia N. Orozco-González +3 more
doaj +1 more source
Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study
PLoS Medicine, 2019 Background Preeclampsia has been suggested to increase the risk of end-stage kidney disease (ESKD); however, most studies were unable to adjust for potential confounders including pre-existing comorbidities such as renal disease and cardiovascular ...
A. Khashan +7 more
semanticscholar +1 more source
Identification of (20R)‐protopanaxadiol from Panax ginseng as a novel anti‐SARS‐CoV‐2 compound
FEBS Open Bio, EarlyView.We established a noninfectious BAC‐based SARS‐CoV‐2 replicon that enables antiviral screening under BSL‐2 conditions. Using this platform, we screened 373 food‐derived compounds and identified (20R)‐protopanaxadiol from Panax ginseng as a novel inhibitor of SARS‐CoV‐2 RNA replication, highlighting the value of safe replicon systems for antiviral ...
Midori Takeda +4 more
wiley +1 more source
Epidemiological Transition of End-Stage Kidney Disease in Oman
Kidney International Reports, 2017 The number of persons receiving renal replacement therapy (RRT) is estimated at more than 2.5 million worldwide, and is growing by 8% annually. Registries in the developing world are not up to standards compared to the United States Renal Data System ...
Faisal Al Ismaili +6 more
doaj +1 more source